Table:
begin	end	state
1	20	cytoplasmic
21	41	transmembrane
42	46	non-cytoplasmic
47	64	transmembrane
65	68	cytoplasmic
69	86	transmembrane
87	91	non-cytoplasmic
92	111	transmembrane
112	121	cytoplasmic
122	141	transmembrane
142	152	non-cytoplasmic
153	176	transmembrane
177	182	cytoplasmic
183	201	transmembrane
202	233	non-cytoplasmic
234	254	transmembrane
255	272	cytoplasmic
273	295	transmembrane
296	305	non-cytoplasmic
306	325	transmembrane
326	332	cytoplasmic
333	353	transmembrane
354	364	non-cytoplasmic
365	393	transmembrane
394	495	cytoplasmic

Input:
>H281DRAFT_03141 FitnessBrowser__Burk376:H281DRAFT_03141
MNTASPTHGWPARLSGIRANVLAGLTSSFALVPECIAFALVAHLNPLMGLYGAFFICTIT
ALFGGRPGMISGAAGSMAVVIVALVVQHGAQYLLATVILSGVLMALFGALRLGKLIRMVP
HPVMLGFVNGLAIVIATAQLAHFRQSTPQGEAWLHGSALAMMCGLVALTMLIVYVLPRVT
RAAPPALVAIVGVGLFAQLLHLPTRTLGDMAHIAGGLPGFNLPDVPLNLETLQVVLPYAV
LIAIVGLLETLLTFNLTDEITETRGQPNRECLALGAANIASGLFGGMGGCAMIGQTMINL
NSGGRSRLSGIVSGVMILMYILFLSPLIERIPLAALVGVMFVVAQQTFAWGSLRVLGKVP
RNDALVIIAVTLITVFSDLAIAVLCGIVIAALNFAWQHAREIHAHVEDRADNRTYVPRGT
LFFASTVRFHELFDPQQDPADVTIDCSHLLLADHSALAALQGLYERYRKAGKQLSVKNLS
EHNRRLLSRAGVGLA

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server